Companies / CVS HEALTH Corp

CVS HEALTH Corp

NYSE: CVSCIK 64803Health CareWOONSOCKET, RIcvshealth.com ↗
Larry Merlo
Chief Executive Officer
Larry Merlo
Photo: The White House from Washington, DC · Public domain · Wikimedia Commons

Financials · FY2025

Revenue$402.07B
Net income$1.77B
Total debt$63.48B
Cash$11.33B
Diluted EPS$1.39
Shares outstanding1.28B

Ownership

1.28B shares outstanding · as of Jul 29, 2026
0.40%Insiders
Ownership
Insiders0.40%5,138,955
Institutions88.34%1,129,832,129
Public float11.26%143,999,285

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Robbins LarryDirector
0.38%4,824,799
Brown C David IIDirector
0.01%129,316
Shah Prem SEVP and Group President
<0.01%61,509
Joyner J. DavidCEOPresident and CEO · Director
<0.01%49,996
Khichi Samrat S.EVP, CPO and General Counsel
<0.01%29,775
Sansone Guy PDirector
<0.01%15,106
Kirby J ScottDirector
<0.01%14,434
Aguirre FernandoDirector
<0.01%10,513
Nelson Steven HEVP and President, Aetna
<0.01%2,924
Gallina John EDirector
<0.01%582

Institutional holders 1,960

View all →
HolderValue% of shares
BlackRock, Inc.$12.75B9.63%
Vanguard Group Inc$9.58B9.44%
State Street Corporation$6.24B4.71%
Capital World Investors$5.37B5.29%
Dodge &amp; Cox$4.96B4.89%
Fmr LLC$3.26B3.21%
JPMORGAN CHASE &amp; CO$2.48B2.44%
Capital International Investors$2.19B2.16%
Geode Capital Management, LLC$2.11B2.30%
Invesco Ltd.$1.91B1.88%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Norges Bank
13F manager
Exit—$-1.67B-21.0M
-100.00%
—
high
Q4 2025
as of
Norges Bank
13F manager
Add—$307.35M+3.9M
+22.62%
20,996,288
1.64% of shares
high
Q1 2026
as of
Millennium Management LLC
13F manager
Trim—$-234.83M-3.3M
-94.39%
194,407
0.02% of shares
high
Q2 2026
as of
BlackRock, Inc.
13F manager
Add—$230.58M+2.2M
+1.84%
123,223,409
9.63% of shares
high
Q2 2026
as of
Pzena Investment Management LLC
13F manager
Trim—$-207.26M-2.0M
-14.55%
11,769,536
0.92% of shares
high
Q2 2023
as of
Barclays PLC
13F manager
Add—$187.42M+2.7M
+97.80%
5,483,154
0.43% of shares
high
Q1 2026
as of
Arrowstreet Capital, Limited Partnership
13F manager
Add—$136.45M+1.9M
+43.98%
6,219,756
0.49% of shares
high
Q4 2025
as of
Barclays PLC
13F manager
Trim—$-130.86M-1.6M
-37.65%
2,730,227
0.21% of shares
high

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CVS——126650100—